Home
About
FAQ
History (26)
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Juniperus
Principal Investigator
A Comparison Between NOACs and Warfarin on Time to Elective Cardioversion.
Principal Investigator
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Soker, Shay
contributes to
Students and Young Investigators Activities at the 2017 TERMIS-Americas Meeting